Pyxis Oncology, Inc. (PYXS)

Pyxis Oncology Statistics

Total Valuation

Pyxis Oncology has a market cap or net worth of $251.17 million. The enterprise value is $185.31 million.

Market Cap	251.17M
Enterprise Value	185.31M

Important Dates

The last earnings date was Monday, November 3, 2025, before market open.

Earnings Date	Nov 3, 2025
Ex-Dividend Date	n/a

Share Statistics

Pyxis Oncology has 62.02 million shares outstanding. The number of shares has increased by 13.72% in one year.

Current Share Class	62.02M
Shares Outstanding	62.02M
Shares Change (YoY)	+13.72%
Shares Change (QoQ)	+1.03%
Owned by Insiders (%)	6.28%
Owned by Institutions (%)	22.17%
Float	40.89M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	85.54
Forward PS	n/a
PB Ratio	3.56
P/TBV Ratio	3.66
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	65.71
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.29, with a Debt / Equity ratio of 0.28.

Current Ratio	4.29
Quick Ratio	3.93
Debt / Equity	0.28
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -87.28% and return on invested capital (ROIC) is -39.41%.

Return on Equity (ROE)	-87.28%
Return on Assets (ROA)	-34.33%
Return on Invested Capital (ROIC)	-39.41%
Return on Capital Employed (ROCE)	-95.84%
Revenue Per Employee	$64,091
Profits Per Employee	-$2.21M
Employee Count	44
Asset Turnover	0.02
Inventory Turnover	n/a

Taxes

Income Tax	-1.88M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +3.82% in the last 52 weeks. The beta is 1.41, so Pyxis Oncology's price volatility has been higher than the market average.

Beta (5Y)	1.41
52-Week Price Change	+3.82%
50-Day Moving Average	2.68
200-Day Moving Average	1.56
Relative Strength Index (RSI)	72.48
Average Volume (20 Days)	783,329

Short Selling Information

The latest short interest is 4.25 million, so 6.85% of the outstanding shares have been sold short.

Short Interest	4.25M
Short Previous Month	4.13M
Short % of Shares Out	6.85%
Short % of Float	10.40%
Short Ratio (days to cover)	4.79

Income Statement

In the last 12 months, Pyxis Oncology had revenue of $2.82 million and -$97.09 million in losses. Loss per share was -$1.57.

Revenue	2.82M
Gross Profit	2.82M
Operating Income	-82.63M
Pretax Income	-98.97M
Net Income	-97.09M
EBITDA	-80.48M
EBIT	-82.63M
Loss Per Share	-$1.57

Balance Sheet

The company has $76.26 million in cash and $19.07 million in debt, giving a net cash position of $57.18 million or $0.92 per share.

Cash & Cash Equivalents	76.26M
Total Debt	19.07M
Net Cash	57.18M
Net Cash Per Share	$0.92
Equity (Book Value)	68.78M
Book Value Per Share	1.10
Working Capital	63.69M

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	100.00%
Operating Margin	-2,930.25%
Pretax Margin	-3,509.47%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Pyxis Oncology does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.72%
Shareholder Yield	-13.72%
Earnings Yield	-40.04%
FCF Yield	n/a

Analyst Forecast

The average price target for Pyxis Oncology is $8.25, which is 103.70% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$8.25
Price Target Difference	103.70%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	30.61%
EPS Growth Forecast (5Y)	-6.34%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1